A new drug combination shows promise for colon cancer patients whose disease no longer responds to standard chemotherapy ...

If trends continue, colorectal cancer could become the leading cause of cancer-related death among young adults ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

Her doctor was concerned, but mentioned that the bleeding could be due to an internal hemorrhoid, which is common after ...

I am a 75-year-old woman with a weight problem. My weight used to fluctuate from 130 pounds to 160 pounds. Then I started to ...

Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting that combination therapy ...

Colon cancer rates are on the rise, especially in people under age 50, and doctors don’t fully understand why.

In this Saturday edition of BI Today, we're talking about why colon cancer is affecting more young people.

Cancer is one of the epidemics of our time. At present, few people have never come into contact with someone who has suffered ...

The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.